|
1
|
Ferlay J, Steliarova-Foucher E,
Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D and
Bray F: Cancer incidence and mortality patterns in Europe:
Estimates for 40 countries in 2012. Eur J Cancer. 49:1374–1403.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vergote I, Oaknin A, Baurain JF, Ananda S,
Wong S, Su X, Wu B, Zhong Z, Warner D and Casado A: A phase 1b,
open-label study of trebananib in combination with paclitaxel and
carboplatin in patients with ovarian cancer receiving interval or
primary debulking surgery. Eur J Cancer. 50:2408–2416. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vergote I, Amant F, Kristensen G, Ehlen T,
Reed NS and Casado A: Primary surgery or neoadjuvant chemotherapy
followed by interval debulking surgery in advanced ovarian cancer.
Eur J Cancer. 47 Suppl 3:S88–S92. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Reed NS, Mangioni C, Malmström H, Scarfone
G, Poveda A, Pecorelli S, Tateo S, Franchi M, Jobsen JJ, Coens C,
et al: Phase III randomised study to evaluate the role of adjuvant
pelvic radiotherapy in the treatment of uterine sarcomas stages I
and II: An European Organisation for Research and Treatment of
Cancer Gynaecological Cancer Group Study (protocol 55874). Eur J
Cancer. 44:808–818. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pinsky PF, Yu K, Kramer BS, Black A, Buys
SS, Partridge E, Gohagan J, Berg CD and Prorok PC: Extended
mortality results for ovarian cancer screening in the PLCO trial
with median 15 years follow-up. Gynecol Oncol. 143:270–275. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj
A, Burnell M, Kalsi JK, Amso NN, Apostolidou S, Benjamin E,
Cruickshank D, et al: Ovarian cancer screening and mortality in the
UK collaborative trial of ovarian cancer screening (UKCTOCS): A
randomised controlled trial. Lancet. 387:945–956. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Derrien T, Johnson R, Bussotti G, Tanzer
A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG,
et al: The GENCODE v7 catalog of human long noncoding RNAs:
Analysis of their gene structure, evolution, and expression. Genome
Res. 22:1775–1789. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Melissari MT and Grote P: Roles for long
non-coding RNAs in physiology and disease. Pflugers Arch.
468:945–958. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin CY, Kleinbrink EL, Dachet F, Cai J, Ju
D, Goldstone A, Wood EJ, Liu K, Jia H, Goustin AS, et al:
Primate-specific oestrogen-responsive long non-coding RNAs regulate
proliferation and viability of human breast cancer cells. Open
Biol. 6:1502622016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang X, Sehgal L, Jain N, Khashab T,
Mathur R and Samaniego F: LncRNA MALAT1 promotes development of
mantle cell lymphoma by associating with EZH2. J Transl Med.
14:3462016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wei S and Wang K: Long noncoding RNAs:
Pivotal regulators in acute myeloid leukemia. Exp Hematol Oncol.
5:302016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhuo C, Jiang R, Lin X and Shao M: LncRNA
H19 inhibits autophagy by epigenetically silencing of DIRAS3 in
diabetic cardiomyopathy. Oncotarget. 8:1429–1437. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Q, Yang L, Hu X, Jiang Y, Hu Y, Liu
Z, Liu J, Wen T, Ma Y, An G and Feng G: Upregulated NNT-AS1, a long
noncoding RNA, contributes to proliferation and migration of
colorectal cancer cells in vitro and in vivo. Oncotarget.
8:3441–3453. 2017.PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta CT)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yeung TL, Leung CS, Li F, Wong SS and Mok
SC: Targeting stromal-cancer cell crosstalk networks in ovarian
cancer treatment. Biomolecules. 6:32016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu T, Zhang X, Gao S, Jing F, Yang Y, Du
L, Zheng G, Li P, Li C and Wang C: Exosomal long noncoding RNA
CRNDE-h as a novel serum-based biomarker for diagnosis and
prognosis of colorectal cancer. Oncotarget. 7:85551–85563. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Spencer SL and Sorger PK: Measuring and
modeling apoptosis in single cells. Cell. 144:926–939. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Du Y, Gong J, Tian X, Yan X, Guo T, Huang
M, Zhang B, Hu X, Liu H, Wang Y, et al: Japonicone A inhibits the
growth of non-small cell lung cancer cells via
mitochondria-mediated pathways. Tumour Biol. 36:7473–7482. 2015.
View Article : Google Scholar : PubMed/NCBI
|
